![](../../files/images/goods/M21864.png)
Valemetostat
CAS No. 1809336-39-7
Valemetostat ( —— )
产品货号. M21864 CAS No. 1809336-39-7
Valemetostat 是 zeste 同源物 1 (EZH1) 和 EZH2.1 增强子的双重抑制剂,它在无细胞测定中抑制含有 EZH1 或 EZH2 作为催化亚基的多梳抑制复合物 2 (PRC2)(IC50 分别 = 8.4 和 2.5 nM) 。
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1596 | 有现货 |
![]() ![]() |
10MG | ¥2811 | 有现货 |
![]() ![]() |
25MG | ¥4682 | 有现货 |
![]() ![]() |
50MG | ¥6683 | 有现货 |
![]() ![]() |
100MG | ¥8829 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Valemetostat
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Valemetostat 是 zeste 同源物 1 (EZH1) 和 EZH2.1 增强子的双重抑制剂,它在无细胞测定中抑制含有 EZH1 或 EZH2 作为催化亚基的多梳抑制复合物 2 (PRC2)(IC50 分别 = 8.4 和 2.5 nM) 。
-
产品描述Valemetostat is a dual inhibitor of enhancer of zeste homolog 1 (EZH1) and EZH2.1 It inhibits polycomb repressive complex 2 (PRC2) containing EZH1 or EZH2 as the catalytic subunit in cell-free assays (IC50s = 8.4 and 2.5 nM, respectively). Valemetostat inhibits trimethylation of histone H3 lysine 27 in HCT116 cells (IC50 = 0.44 nM). It inhibits the growth of Karpas-422 diffuse large B cell lymphoma (DLBCL) cells (GI50 = 4.8 nM).(In Vitro):Valemetostat (1-1000 nM) strongly and specifically inhibits EZH1 and EZH2 with IC50 values <10 nM.Valemetostat (100 nM; 7 d) effectively removes H3K27me3 and also prevents unexpected gain of H3K27me3.Valemetostat (0.1-100 nM; 7 d) potently inhibits H3K27me3 by low-dose treatment in the sensitive lymphoma types.(In Vivo):Valemetostat (0.01 mg/g; i.p.; once) prevents the changes of H3K27me3 after exercise training.
-
体外实验Valemetostat (1-1000 nM) strongly and specifically inhibits EZH1 and EZH2 with IC50 values <10 nM.Valemetostat (100 nM; 7 d) effectively removes H3K27me3 and also prevents unexpected gain of H3K27me3. Valemetostat (0.1-100 nM; 7 d) potently inhibits H3K27me3 by low-dose treatmentin the sensitive lymphoma types.
-
体内实验Valemetostat (0.01 mg/g; i.p.; once) prevents the changes of H3K27me3 after exercise training. Animal Model:Male C57BL/6J mice with chronic and acute running exercise or without exercise Dosage:0.01 mg/g Administration:Intraperitoneal injection; 0.01 mg/g; 30 min before the start of running exercise Result:Significantly increased the level of H3K27me3 , slightly decresed EZH1 level , upregulated the EZH2 level and increased the level of phosphorylated AMPK after exercise. Repressed myonuclear H3K27me3 accumulation during training and caused a failure of adaptive changes.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体EZH1/2
-
研究领域——
-
适应症——
化学信息
-
CAS Number1809336-39-7
-
分子量488.02
-
分子式C26H34ClN3O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 70 mg/mL (143.44 mM)
-
SMILESCC1=CC(=C(C(=O)N1)CNC(=O)C2=CC(=C3C(=C2C)OC(O3)(C)C4CCC(CC4)N(C)C)Cl)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/new12.jpg)
![](/themes/theme/en/images/gift.jpg)
![](/themes/theme/en/images/ct2.png)
关联产品
-
Senecivernine N-oxid...
The herbs of Senecio inaequidens D.C
-
Inaxaplin
Inaxaplin 是一种载脂蛋白 L1 (APOL1) 功能抑制剂(WO2020131807,化合物 2)。 Inaxaplin 可用于肾脏疾病的研究。
-
Nardosinone
Nardosinone 对 Ang II 诱导的 H9c2 细胞肥大有抑制作用,可能是通过靶向 PI3K/Akt 和 MEK/ERK 信号通路介导的。